https://www.sanofi.com/en/media-room/press-releases/2020/2020-10-28-06-00-00-2115626
Sanofi and GSK to support COVAX with 200 million doses of adjuvanted, recombinant protein-based COVID-19 vaccine *COVAX Facility is led by Gavi and aims to...
sanofigsksupportcovaxmillion
https://www.mdpi.com/2076-393X/12/7/754
Periodontal disease (PD) is caused by microbial dysbiosis and accompanying adverse inflammatory responses. Due to its high incidence and association with...
flagellinadjuvantedtrivalentmucosalvaccine
https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.00295/full
Elderly people are at high risk for influenza-related morbidity and mortality due to progressive immunosenescence. While toll-like receptor (TLR) agonist con...
young and agedimmune responsesfrontiersimprovedmice